Utility of CYP2D6 Genotyping to Improve the Efficacy and Safety of Tramadol
Utility of CYP2D6 Genotyping to Improve the Efficacy and Safety of Tramadol
Active, not recruiting · NCT05657704 · Registry updated 2026-08-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Utility of CYP2D6 Genotyping to Improve the Efficacy and Safety of Tramadol | Acute Pain, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms | Active, not recruiting | Phase 4 | 2026-08-19 | NCT05657704 |
8 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fundación para la Investigación Biomédica Hospital La Princesa | Madrid | Spain | 1 |
| Hospital General Universitario de Burgos y Clínica Colina | Burgos | Spain | 1 |
| Hospital Universitario Clínico San Carlos | Madrid | Spain | 9 |
| Hospital Universitario Puerta de Hierro | Majadahonda | Spain | 2 |
| Hospital Universitario San Juan de Alicante | Alicante | Spain | 5 |
| Hospital Universitaro La Paz | Madrid | Spain | 1 |
| Hospital Univesitario Ramón y Cajal | Madrid | Spain | 1 |
| Hostpital Universitario Fundación Jiménez Díaz | Madrid | Spain | 1 |